Neurocrine Biosciences' Series A - II Round

Neurocrine Biosciences raised a round of funding on January 01, 1996.

Neurocrine Biosciences is a San Diego based biotechnology company focused on neurologic and endocrine related disorders. The Company's three late-stage clinical programs are: elagolix, a gonadotropin-…

Articles about Neurocrine Biosciences' Series A - II Round: